Skip to main navigation Skip to search Skip to main content

Genetic disorders of adrenal hormone synthesis

  • M. I. New

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Steroid 21-hydroxylase is the enzyme involved in 90-95% of cases of congenital adrenal hyperplasia (CAH). The general feature of CAH, which results from an enzymatic block at any stage in the synthesis of cortisol, is increased serum adrenocorticotropin and thus stimulated adrenal synthesis of steroids proximal to the block. All enzyme defects causing CAH are autosomal recessive traits. The early steps in cortisol synthesis are common to adrenal and gonadal steroid pathways, thus CAH caused by dysfunction of the enzymes supporting these steps is also characterized by insufficient production of gonadal hormones, causing impaired genital development in the genetic male. The absence of or severe reduction of steroid 21-hydroxylase activity also causes prenatal hypersecretion of androgens by the adrenal cortex, which results in external genital ambiguity in genetic females. This paper discusses the classical and nonclassical forms of CAH, their aetiology, diagnosis and treatment, and also describes recent advances in prenatal diagnosis and treatment which avoids the need for corrective genital plastic surgery in infancy.

Original languageEnglish
Pages (from-to)22-33
Number of pages12
JournalHormone Research
Volume37
Issue numberSUPPL. 3
DOIs
StatePublished - 1992
Externally publishedYes

Keywords

  • Congenital adrenal hyperplasia
  • Gene conversion
  • HLA
  • Prenatal treatment
  • Steroid 21-hydroxylase

Fingerprint

Dive into the research topics of 'Genetic disorders of adrenal hormone synthesis'. Together they form a unique fingerprint.

Cite this